deltatrials
Completed PHASE2/PHASE3 NCT03907267

Taurine in Peripartum Cardiomyopathy

Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy

Sponsor: Ain Shams University

Updated 5 times since 2019 Last updated: Jan 26, 2020 Started: Jan 1, 2015 Primary completion: Dec 1, 2019 Completion: Jan 1, 2020

A PHASE2/PHASE3 clinical study on Peripartum Cardiomyopathy, this trial is completed. The trial is conducted by Ain Shams University and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2019 – ~Feb 2020 · 9 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  5. May 2019 — Feb 2020 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ain Shams University
Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations